Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-FasL Inhibition to Target Cell Death Signaling Pathways for Practical Human Application

Affiliations

• ¹ Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
• ² PinCell srl, Milano, Italy; DermoLab, University of Modena and Reggio Emilia, Modena, Italy.
• ³ PinCell srl, Milano, Italy.
• ⁴ PinCell srl, Milano, Italy. Electronic address: carlo.pincelli@unimore.it.
• ⁵ Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Electronic address: aberi@med.niigata-u.ac.jp.